Weil, Gotshal & Manges, a multinational law firm, has represented major corporations over its nearly century-long history.
Weil, Gotshal & Manges, longtime Wall Street law firm, plans wind down
Original reporting
CNBC: read the full reportRelated stories
Restaurant Brands reports mixed results as Burger King's U.S. turnaround shows signs of success
Burger King's U.S. restaurants outperformed, while Popeyes disappointed.
Merck tops quarterly estimates, hikes profit outlook as new form of Keytruda shows strength
Merck's immunotherapy Keytruda, including a newer injectable form of the drug, showed stronger-than-expected sales.
President of the European Central Bank Christine Lagarde to stand down in February

UK government borrowing costs fall as City welcomes ‘no harm’ budget – business live
Premier owner Whitbread says budget business rate measures ‘will do much to mitigate’ damage of past two budgets to hospitality sector Mortgage approvals across the UK sank to a near three-year low last month, while consumer lending grew at the fastest rate in eight years. British lenders approved 53,443 mortgages for house purchase in September, the lowest number since December 2023, according to the latest Bank of England money and credit data. This marks the third consecutive monthly decline, an unwelcome hat-trick, making Halloween for housebuilders more trick than treat, and takes approvals to their lowest level since December 2023. The current run-rate sits 10.8% below the five-year average and 16.9% below the ten-year average, pointing to demand that remains stubbornly subdued. The value of approvals fell even faster, down 4.9% month-on-month and 17.7% year-on-year to £13.7b

Poundland's future hangs in the balance as chain edges towards collapse
Poundland's bosses have filed a notice of intention to appoint administrators to the business.
Eli Lilly is about to report earnings. Here's what to expect
Eli Lilly is slated to report third-quarter earnings and revenue, which will likely be fueled by its obesity drug Zepbound and diabetes counterpart Mounjaro.